Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carter M Suryadevara

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2016
Immunotherapy Gone Viral: Bortezomib and oHSV Enhance Antitumor NK-Cell ActivityCarter M Suryadevara, Katherine A Riccione, John H Sampson
Operative Neurosurgery (Hagerstown, Md.)|March 26, 2026
Endoscopic Endonasal Resection of Diaphragma Sellae Meningioma: 2-Dimensional Operative VideoCarter M Suryadevara, James Ryoo, Emma Bacus, et al.
Oncoimmunology|January 23, 2015
Chimeric antigen receptor engineered T cells can eliminate brain tumors and initiate long-term protection against recurrenceLaura A Johnson, Luis Sanchez-Perez, Carter M Suryadevara, et al.
Current Opinion in Virology|April 8, 2015
Potentiating oncolytic viral therapy through an understanding of the initial immune responses to oncolytic viral infectionChristopher A Alvarez-Breckenridge, Bryan D Choi, Carter M Suryadevara, et al.
Surgical Neurology International|March 5, 2026
Regression of pituitary macroadenoma after endovascular embolization of thoracic cerebrospinal fluid-venous fistula for symptomatic intracranial hypotension: Illustrative caseCarter M Suryadevara, Debarati Bhanja, Albert Liu, et al.
Expert Review of Clinical Immunology|October 3, 2017
Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3Teilo H Schaller, Kristen A Batich, Carter M Suryadevara, et al.
Journal of Visualized Experiments : Jove|March 6, 2015
Generation of CAR T cells for adoptive therapy in the context of glioblastoma standard of careKatherine Riccione, Carter M Suryadevara, David Snyder, et al.
Oncoimmunology|January 23, 2015
Leveraging chemotherapy-induced lymphopenia to potentiate cancer immunotherapyLuis Sanchez-Perez, Carter M Suryadevara, Bryan D Choi, et al.
Cancers|October 27, 2022
Advances and Hurdles in CAR T Cell Immune Therapy for Solid TumorsFrancesco Boccalatte, Roberto Mina, Andrea Aroldi, et al.
Expert Opinion on Emerging Drugs|May 26, 2016
Emerging immunotherapies for glioblastomaRupen Desai, Carter M Suryadevara, Kristen A Batich, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2016
Immunotherapy Gone Viral: Bortezomib and oHSV Enhance Antitumor NK-Cell ActivityCarter M Suryadevara, Katherine A Riccione, John H Sampson
Operative Neurosurgery (Hagerstown, Md.)|March 26, 2026
Endoscopic Endonasal Resection of Diaphragma Sellae Meningioma: 2-Dimensional Operative VideoCarter M Suryadevara, James Ryoo, Emma Bacus, et al.
Oncoimmunology|January 23, 2015
Chimeric antigen receptor engineered T cells can eliminate brain tumors and initiate long-term protection against recurrenceLaura A Johnson, Luis Sanchez-Perez, Carter M Suryadevara, et al.
Current Opinion in Virology|April 8, 2015
Potentiating oncolytic viral therapy through an understanding of the initial immune responses to oncolytic viral infectionChristopher A Alvarez-Breckenridge, Bryan D Choi, Carter M Suryadevara, et al.
Surgical Neurology International|March 5, 2026
Regression of pituitary macroadenoma after endovascular embolization of thoracic cerebrospinal fluid-venous fistula for symptomatic intracranial hypotension: Illustrative caseCarter M Suryadevara, Debarati Bhanja, Albert Liu, et al.
Expert Review of Clinical Immunology|October 3, 2017
Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3Teilo H Schaller, Kristen A Batich, Carter M Suryadevara, et al.
Journal of Visualized Experiments : Jove|March 6, 2015
Generation of CAR T cells for adoptive therapy in the context of glioblastoma standard of careKatherine Riccione, Carter M Suryadevara, David Snyder, et al.
Oncoimmunology|January 23, 2015
Leveraging chemotherapy-induced lymphopenia to potentiate cancer immunotherapyLuis Sanchez-Perez, Carter M Suryadevara, Bryan D Choi, et al.
Cancers|October 27, 2022
Advances and Hurdles in CAR T Cell Immune Therapy for Solid TumorsFrancesco Boccalatte, Roberto Mina, Andrea Aroldi, et al.
Expert Opinion on Emerging Drugs|May 26, 2016
Emerging immunotherapies for glioblastomaRupen Desai, Carter M Suryadevara, Kristen A Batich, et al.
Pageof 4